Integris Medtech IPO Analysis: Should You Apply? GMP, Review & Details
TopFund Research
Published · Updated
TL;DR
- Opens 27 Nov, closes 01 Dec 2026.
- GMP not yet available for this IPO.
- Expected listing: 04 Dec 2026 on BSE, NSE.
- Full company analysis, risk factors and FAQs below — this is educational content, not a buy/subscribe recommendation.
Integris Medtech is a MAINBOARD IPO in the Medical Equipment & Supplies sector.
Integris Medtech IPO — Key Details
| Field | Value |
|---|---|
| Price Band | TBA |
| GMP | Not yet available |
| Open Date | 27 Nov 2026 |
| Close Date | 01 Dec 2026 |
| Listing Date | 04 Dec 2026 |
Company Overview
Integris Medtech Ltd, established in 2008, is a diversified Indian company specializing in medical products and laboratory solutions. It develops and sells a wide range of medical devices, particularly in cardiovascular and laboratory segments. The company operates manufacturing facilities in India, Germany, and the Netherlands, serving over 65 international markets. Its customer base includes more than 9,500 laboratories and 2,000 hospitals, supported by a portfolio of over 22,000 SKUs across more than 200 brands.
Financial Performance
Total income was ₹1,369.66 Cr in the year ending 31 Mar 2023, increasing to ₹1,582.26 Cr by 31 Mar 2024, then rising significantly to ₹1,959.58 Cr by 31 Mar 2025. However, the most recent figure of ₹508.93 Cr as of 30 Jun 2025 is only for a 9-month period, not a full year, so it isn't directly comparable. Profit After Tax was a loss of ₹40.54 Cr in the year ending 31 Mar 2023, improving to a loss of ₹4.88 Cr by 31 Mar 2024. The company then reported a profit of ₹70.68 Cr for the year ending 31 Mar 2025, which further increased to ₹267.57 Cr as of 30 Jun 2025, though this is a 9-month figure and not a full year.
Objects of the Issue
The funds raised will be used for the repayment of certain outstanding borrowings (₹509.85 Cr), support for wholly-owned subsidiaries (₹93.87 Cr), support for step-down subsidiaries (₹415.98 Cr), and general corporate purposes.
Strengths & Weaknesses
Strengths
Diverse product portfolio in medical devices; Strong international market presence; Positive recent profit trend
Weaknesses
Recent negative profit figures; Dependence on international markets; High competition in medical equipment sector
Understanding Grey Market Premium (GMP)
The grey market refers to the unofficial trading of shares before they are listed on the stock exchange. It can indicate the expected demand for an IPO based on informal trading activity.
Peer Comparison
- Laxmi Dental: P/E 53.95
- Poly Medicure: P/E 56.02
Should You Apply for Integris Medtech IPO?
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their investment goals and risk tolerance.
Those averse to high competition and recent profit instability may consider avoiding this IPO.
This is general risk-profile education, not a personal recommendation to apply or avoid this specific IPO — TopFund is not a SEBI-registered investment adviser.
Listing Day Risks
Listing gains are not guaranteed and can be influenced by market conditions, investor sentiment, and overall demand for the stock on its debut day.
Trending Searches
Disclaimer: This is educational content, not investment advice. GMP is an unofficial grey-market indicator, unregulated and never guaranteed. TopFund is not a SEBI-registered investment adviser — please do your own research or consult a qualified adviser before applying to any IPO.
Frequently Asked Questions
What is the lot size for the IPO?
The lot size has not been specified.
What is the minimum investment required?
The minimum investment amount has not been specified.
What are the dates for the IPO?
The IPO opens on 27 Nov 2026 and closes on 01 Dec 2026.
When will the shares be listed?
The listing date is set for 04 Dec 2026.
What does GMP mean?
GMP stands for Grey Market Premium, indicating the expected price of the stock in the grey market.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.
TopFund Weekly Digest
Every Sunday — live IPO GMP, top mutual funds & market news. Free, no spam.
No spam · Unsubscribe anytime · 6 readers